CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The OSTEOproSPINE project focuses on a new therapy for chronic back pain using a bone regeneration product that combines a growth factor with a supportive matrix. The clinical trial aims to assess its safety and effectiveness for spinal fusion compared to traditional methods.
We propose a clinical program for the evaluation of a novel bone-regeneration product OSTEOproSPINE as a treatment for intractable chronic back pain.
OSTEOproSPINE is a novel bone regeneration therapy composed of OSTEOGROW (recombinant human bone morphogenetic protein 6 [rhBMP6] delivered in autologous peripheral blood coagulum) reinforced with allograft (a compression resistant matrix).
OSTEOproSPINE is designed to guide the formation of new bone at extra-skeletal site and replace autograft har…
UNIVERSITY OF ZAGREB, SCHOOL OF MEDICINE
SVEUCILISTE U ZAGREBU MEDICINSKI FAKULTET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Croatia, Kalinovica
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
MEDIZINISCHE UNIVERSITAET WIEN
Austria, Wien
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
JOHANNES KEPLER UNIVERSITAT LINZ UNIVERSITY OF LINZ JOHANNES KEPLER UNIVERSITY OF LINZ JKU
Austria, Linz
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
